Persistence With Biologic Therapies in the Medicare Coverage Gap
For patients who reached the Medicare Part D coverage gap, discontinuation was more likely for patients taking osteoporosis medication.
New Studies Highlight JAK Inhibitors’ Power as AD Treatment
Reducing Polycythemia Vera–Associated Thrombotic Risk Through Iron Regulation
Financial, Housing, Food Insecurity Raises Risk of Hospital, ED Visits
ANTHEM-UC: Icotrokinra (JNJ-2113) Shows Promise for Ulcerative Colitis